Company intelligence / Profile preview
Unipharm
Israelunipharm.global ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Unipharm is a leading Israeli family-owned generic pharmaceutical company with over 45 years of experience. It specializes in developing and manufacturing oral solid and solution formulations. The company is often the first to launch generics in Israel and has an EU-recognized GMP-certified facility. Its products cover a wide range of therapeutic areas and are available for out-licensing globally.
- Therapeutic areas
- NeurologyInfectious DiseasesMen's HealthOtherCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborates with international generic players for out-licensing and global distribution since 2017
Beyond the preview
Go deeper on Unipharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Unipharm.